Prognostic value of the autophagy markers LC3 and p62/SQSTM1 in early-stage non-small cell lung cancer

Oncotarget

Volumn 7, Issue 26, 2016, Pages 39544-39555

  Schläfli, Anna M ^a   Adams, Olivia ^a   Galván, José A ^a   Gugger, Mathias ^a,b   Savic, Spasenija ^c   Bubendorf, Lukas ^c   Schmid, Ralph A ^d   Becker, Karl Friedrich ^e   Tschan, Mario P ^a   Langer, Rupert ^a   Berezowska, Sabina ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Laboratoire Promed   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d UNIVERSITY OF BERN   (Switzerland)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Autophagy; Immunohistochemistry; LC3; Non small cell lung cancer; P62 SQSTM1

Indexed keywords

ONCOPROTEIN; PROTEIN LIGHT CHAIN 3; PROTEIN P62; UNCLASSIFIED DRUG; LIGHT CHAIN 3, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; P62 PROTEIN, HUMAN; RNA BINDING PROTEIN;

AGED; ARTICLE; AUTOPHAGY; CANCER PROGNOSIS; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; CELL NUCLEUS; CYTOPLASM; GENE EXPRESSION REGULATION; LUNG TUMOR; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDY; TISSUE MICROARRAY; TREATMENT OUTCOME;

AGED; AUTOPHAGY; CARCINOMA, NON-SMALL-CELL LUNG; CELL NUCLEUS; CYTOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; RNA-BINDING PROTEINS; TISSUE ARRAY ANALYSIS; TREATMENT OUTCOME;

EID: 84982994339     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.9647     Document Type: Article

References (39)

1. Travis WD, Brambilla E, Burke AP, Marx A and Nicholson AG. (2015). WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. In: Bosman FT, Jaffe ES, Lakhani SR and Ohgaki H, eds. World Health Organization Classification of Tumours. (Lyon: International Agency for Research on Cancer (IARC)).
2. Kuma A and Mizushima N. Physiological role of autophagy as an intracellular recycling system: with an emphasis on nutrient metabolism. Semin Cell Dev Biol. 2010; 21:683-690.
3. Feng Y, He D, Yao Z and Klionsky DJ. The machinery of macroautophagy. Cell Res. 2014; 24:24-41.
4. Deretic V. Autophagy in immunity and cell-autonomous defense against intracellular microbes. Immunol Rev. 2011; 240:92-104.
5. White E. The role for autophagy in cancer. J Clin Invest. 2015; 125:42-46.
6. Rao S, Tortola L, Perlot T, Wirnsberger G, Novatchkova M, Nitsch R, Sykacek P, Frank L, Schramek D, Komnenovic V, Sigl V, Aumayr K, Schmauss G, Fellner N, Handschuh S, Glosmann M, et al. A dual role for autophagy in a murine model of lung cancer. Nat Commun. 2014; 5:3056.
7. Strohecker AM and White E. Autophagy promotes BrafV600E-driven lung tumorigenesis by preserving mitochondrial metabolism. Autophagy. 2014; 10:384-385.
8. Chen HY and White E. Role of autophagy in cancer prevention. Cancer Prev Res (Phila). 2011; 4:973-983.
9. Takamura A, Komatsu M, Hara T, Sakamoto A, Kishi C, Waguri S, Eishi Y, Hino O, Tanaka K and Mizushima N. Autophagy-deficient mice develop multiple liver tumors. Genes Dev. 2011; 25:795-800.
10. Parzych KR and Klionsky DJ. An overview of autophagy: morphology, mechanism, and regulation. Antioxid Redox Signal. 2014; 20:460-473.
11. Noda T, Matsunaga K, Taguchi-Atarashi N and Yoshimori T. Regulation of membrane biogenesis in autophagy via PI3P dynamics. Semin Cell Dev Biol. 2010; 21:671-676.
12. Nakatogawa H, Suzuki K, Kamada Y and Ohsumi Y. Dynamics and diversity in autophagy mechanisms: lessons from yeast. Nat Rev Mol Cell Biol. 2009; 10:458-467.
13. Shpilka T, Weidberg H, Pietrokovski S and Elazar Z. Atg8: an autophagy-related ubiquitin-like protein family. Genome Biol. 2011; 12:226.
14. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, Kominami E, Ohsumi Y and Yoshimori T. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000; 19:5720-5728.
15. Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, Agnello M, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016; 12:1-222.
16. Galluzzi L, Pietrocola F, Bravo-San Pedro JM, Amaravadi RK, Baehrecke EH, Cecconi F, Codogno P, Debnath J, Gewirtz DA, Karantza V, Kimmelman A, Kumar S, Levine B, Maiuri MC, Martin SJ, Penninger J, et al. Autophagy in malignant transformation and cancer progression. EMBO J. 2015; 34:856-880.
17. Mijaljica D, Nazarko TY, Brumell JH, Huang WP, Komatsu M, Prescott M, Simonsen A, Yamamoto A, Zhang H, Klionsky DJ and Devenish RJ. Receptor protein complexes are in control of autophagy. Autophagy. 2012; 8:1701-1705.
18. Rogov V, Dotsch V, Johansen T and Kirkin V. Interactions between autophagy receptors and ubiquitin-like proteins form the molecular basis for selective autophagy. Mol Cell. 2014; 53:167-178.
19. Inoue D, Suzuki T, Mitsuishi Y, Miki Y, Suzuki S, Sugawara S, Watanabe M, Sakurada A, Endo C, Uruno A, Sasano H, Nakagawa T, Satoh K, Tanaka N, Kubo H, Motohashi H, et al. Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma. Cancer Sci. 2012; 103:760-766.
20. Karpathiou G, Sivridis E, Koukourakis MI, Mikroulis D, Bouros D, Froudarakis ME and Giatromanolaki A. Light-chain 3A autophagic activity and prognostic significance in non-small cell lung carcinomas. Chest. 2011; 140:127-134.
21. Zois CE, Giatromanolaki A, Sivridis E, Papaiakovou M, Kainulainen H and Koukourakis MI. «Autophagic flux» in normal mouse tissues: focus on endogenous LC3A processing. Autophagy. 2011; 7:1371-1378.
22. Martinet W, Schrijvers DM, Timmermans JP, Bult H and De Meyer GR. Immunohistochemical analysis of macroautophagy: recommendations and limitations. Autophagy. 2013; 9:386-402.
23. Mizushima N and Yoshimori T. How to interpret LC3 immunoblotting. Autophagy. 2007; 3:542-545.
24. Schlafli AM, Berezowska S, Adams O, Langer R and Tschan MP. Reliable LC3 and p62 autophagy marker detection in formalin fixed paraffin embedded human tissue by immunohistochemistry. Eur J Histochem. 2015; 59:2481.
25. Liu JL, Chen FF, Lung J, Lo CH, Lee FH, Lu YC and Hung CH. Prognostic significance of p62/SQSTM1 subcellular localization and LC3B in oral squamous cell carcinoma. Br J Cancer. 2014; 111:944-954.
26. Iwadate R, Inoue J, Tsuda H, Takano M, Furuya K, Hirasawa A, Aoki D and Inazawa J. High Expression of p62 Protein Is Associated with Poor Prognosis and Aggressive Phenotypes in Endometrial Cancer. The American journal of pathology. 2015; 185:2523-2533.
27. Luo RZ, Yuan ZY, Li M, Xi SY, Fu J and He J. Accumulation of p62 is associated with poor prognosis in patients with triple-negative breast cancer. Onco Targets Ther. 2013; 6:883-888.
28. Rolland P, Madjd Z, Durrant L, Ellis IO, Layfield R and Spendlove I. The ubiquitin-binding protein p62 is expressed in breast cancers showing features of aggressive disease. Endocr Relat Cancer. 2007; 14:73-80.
29. Burdelski C, Reiswich V, Hube-Magg C, Kluth M, Minner S, Koop C, Graefen M, Heinzer H, Tsourlakis MC, Wittmer C, Huland H, Simon R, Schlomm T, Sauter G and Steurer S. Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer. Clin Cancer Res. 2015; 21:3471-3479.
30. Jiang T, Harder B, Rojo de la Vega M, Wong PK, Chapman E and Zhang DD. p62 links autophagy and Nrf2 signaling. Free Radic Biol Med. 2015; 88:199-204.
31. Inami Y, Waguri S, Sakamoto A, Kouno T, Nakada K, Hino O, Watanabe S, Ando J, Iwadate M, Yamamoto M, Lee MS, Tanaka K and Komatsu M. Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells. J Cell Biol. 2011; 193:275-284.
32. Moscat J, Diaz-Meco MT and Wooten MW. Signal integration and diversification through the p62 scaffold protein. Trends Biochem Sci. 2007; 32:95-100.
33. Nakamura K, Kimple AJ, Siderovski DP and Johnson GL. PB1 domain interaction of p62/sequestosome 1 and MEKK3 regulates NF-kappaB activation. J Biol Chem. 2010; 285:2077-2089.
34. Pankiv S, Lamark T, Bruun JA, Overvatn A, Bjorkoy G and Johansen T. Nucleocytoplasmic shuttling of p62/SQSTM1 and its role in recruitment of nuclear polyubiquitinated proteins to promyelocytic leukemia bodies. J Biol Chem. 2010; 285:5941-5953.
35. Clausen TH, Lamark T, Isakson P, Finley K, Larsen KB, Brech A, Overvatn A, Stenmark H, Bjorkoy G, Simonsen A and Johansen T. p62/SQSTM1 and ALFY interact to facilitate the formation of p62 bodies/ALIS and their degradation by autophagy. Autophagy. 2010; 6:330-344.
36. Kau TR, Way JC and Silver PA. Nuclear transport and cancer: from mechanism to intervention. Nat Rev Cancer. 2004; 4:106-117.
37. Sobin LH, Gospodarowicz MK and Christian Wittekind C. (2009). International Union Against Cancer (UICC): TNM Classification of Malignant Tumours. Wiley-Blackwell), pp. 336.
38. Cihoric N, Savic S, Schneider S, Ackermann I, BichselNaef M, Schmid RA, Lardinois D, Gugger M, Bubendorf L, Zlobec I and Tapia C. Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer. Br J Cancer. 2014; 110:2914-2922.
39. Zlobec I, Suter G, Perren A and Lugli A. A next-generation tissue microarray (ngTMA) protocol for biomarker studies. J Vis Exp. 2014;:51893.